Product Information
XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $19.4545 per EA under NDC 50458058451. Its NADAC has been published 601 times since Feb 18, 2015.
FDA first approved this application on Jul 1, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Rivaroxaban market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458058451
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA022406FDA Approved
7/1/2011
TE Code
AB
On Market Since
9/16/2014
Price Statistics
The NADAC for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK has been published 601 times since Feb 18, 2015, and over the history we have for it it has risen 89.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.4545 per EA |
|---|---|
| All-time high | $19.5229 (Jun 10, 2026) |
| All-time low | $10.0884 (Mar 18, 2015) |
| 52-week high | $19.5229 |
| 52-week low | $19.0711 |
| Median price | $15.1162 |
| Average price | $15.1766 |
| Largest weekly change | +8.0% (Jan 10, 2018) |
| Weeks tracked | 601 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Rivaroxaban market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK?
The current National Average Drug Acquisition Cost (NADAC) for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK, manufactured by Janssen Pharmaceuticals Inc., is $19.4545 per EA (NDC 50458058451), effective Aug 19, 2026.
How has the price of XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK changed over time?
Over the history we have for it, the NADAC for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK has risen 89.0%. It has been tracked across 601 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK?
Since Feb 18, 2015, the NADAC for XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK has ranged from a low of $10.0884 (Mar 18, 2015) to a high of $19.5229 (Jun 10, 2026), with a median of $15.1162 per EA.
Are there cheaper alternatives to XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK?
No other NADAC-published product currently shares the active ingredient and strength of XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK?
XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK (NDC 50458058451) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.